
  
    
      
        Background_NNP
        The_DT B_NNP cell_NN antigen_NN receptor_NN (_( BCR_NNP )_) is_VBZ a_DT multi-subunit_JJ
        complex_NN that_IN acts_NNS as_IN a_DT key_JJ sensor_NN regulating_VBG the_DT response_NN
        of_IN lymphocytes_NNS to_TO their_PRP$ environment_NN (_( reviewed_VBN in_IN [_NN 1_CD 2_CD 3_CD 4_CD
        5_CD 6_CD 7_CD ]_NN )_) ._. In_IN mature_VBP B_NNP cells_NNS ,_, activation_NN through_IN the_DT BCR_NNP
        stimulates_NNS cellular_JJ proliferation_NN and_CC differentiation_NN ._. In_IN
        immature_NN B_NNP cells_NNS ,_, activation_NN through_IN the_DT BCR_NNP induces_VBZ either_CC
        a_DT state_NN of_IN unresponsiveness_NNS ,_, termed_VBD anergy_NN ,_, or_CC death_NN by_IN
        apoptosis_NNS ,_, depending_VBG on_IN the_DT physical_JJ nature_NN and_CC
        concentration_NN of_IN the_DT antigen_NN [_NN 8_CD 9_CD 10_CD 11_CD 12_CD 13_CD 14_CD 15_CD 16_CD 17_CD
        18_CD 19_CD 20_CD 21_CD 22_CD 23_CD 24_CD 25_CD ]_NN ._. In_IN some_DT B_NNP cell_NN lymphomas_NNS ,_,
        activation_NN through_IN the_DT BCR_NNP can_MD induce_VB cell_NN cycle_NN arrest_NN and_CC
        apoptosis_NNS 
        in_IN vitro_NN and_CC tumor_NN dormancy_NN 
        in_IN vivo_NN [_NN 19_CD 26_CD 27_CD 28_CD ]_NN ._. The_DT core_NN of_IN
        the_DT multi-subunit_JJ BCR_NNP is_VBZ membrane-bound_JJ immunoglobulin_NN
        (_( mIg_NN )_) ,_, which_WDT is_VBZ non-covalently_JJ associated_VBN with_IN two_CD
        co-receptor_JJ molecules_NNS ,_, CD_NNP 79_CD a_DT (_( Igα_NNP )_) and_CC CD_NNP 79_CD b_SYM (_( Igβ_NNP )_) ,_,
        products_NNS of_IN the_DT mb-_NN 1_CD and_CC B_NNP 29_CD genes_NNS [_NN 29_CD 30_CD ]_NN ._. The_DT
        biochemical_JJ changes_NNS induced_VBN by_IN engagement_NN of_IN the_DT BCR_NNP are_VBP
        extensive_JJ and_CC include_VBP an_DT increase_NN in_IN tyrosine_NN
        phosphorylation_NN of_IN several_JJ intracellular_NN proteins_NNS ,_,
        hydrolysis_NNS of_IN membrane_NN phospholipids_NNS ,_, fluxes_NNS in_IN the_DT
        concentration_NN of_IN intracellular_NN free_JJ Ca_MD 2_CD +_NN ,_, activation_NN of_IN
        several_JJ serine_NN /_NN threonine_NN kinases_NNS including_VBG components_NNS of_IN
        the_DT MAP_NNP kinase_NN pathway_NN ,_, and_CC changes_NNS in_IN the_DT activities_NNS of_IN a_DT
        panel_NN of_IN transcription_NN factors_NNS ._. Although_IN much_JJ is_VBZ known_VBN
        about_IN the_DT biochemical_JJ changes_NNS occurring_VBG in_IN response_NN to_TO
        BCR-mediated_NNP activation_NN ,_, the_DT differences_NNS in_IN the_DT signal_NN
        transduction_NN pathways_NNS that_WDT give_VBP rise_NN to_TO the_DT different_JJ
        cellular_JJ responses_NNS following_VBG activation_NN of_IN the_DT same_JJ
        receptor_NN in_IN immature_NN versus_CC mature_VBP cells_NNS have_VBP yet_RB to_TO be_VB
        elucidated_JJ completely_RB (_( discussed_VBN in_IN detail_NN in_IN refs_NNS ._. [_NN 7_CD ]_NN
        )_) ._.
        Some_DT of_IN the_DT earliest_JJS changes_NNS that_WDT occur_VBP following_VBG BCR_NNP
        engagement_NN are_VBP the_DT activation_NN of_IN several_JJ non-receptor_JJ
        protein_NN tyrosine_NN kinases_NNS (_( PTKs_NNP )_) ,_, including_VBG p_NN 55_CD 
        blk_NN (_( Blk_NNP )_) ,_, p_NN 59_CD 
        fyn_NN (_( Fyn_NNP )_) and_CC p_NN 53_CD /_NN 56_CD 
        lyn_NN (_( Lyn_NNP )_) of_IN the_DT Src_NNP family_NN [_NN 31_CD ]_NN ,_,
        Btk_NNP of_IN the_DT Itk_NNP /_NN Tec_NNP family_NN [_NN 32_CD 33_CD ]_NN and_CC p_NN 72_CD 
        Syk_NNP (_( Syk_NNP )_) of_IN the_DT Syk_NNP /_NN ZAP-_NNP 70_CD family_NN [_NN
        34_CD ]_NN ._. The_DT importance_NN of_IN Syk_NNP in_IN BCR_NNP signaling_VBG and_CC
        lymphocyte_NN development_NN has_VBZ been_VBN clearly_RB demonstrated_VBN using_VBG
        gene_NN inactivation_NN approaches_NNS ._. Although_IN 
        syk_NN -_: deficient_NN mice_NNS die_VBP perinatally_RB ,_,
        analysis_NN of_IN radiation_NN chimeras_NNS reconstituted_JJ with_IN fetal_JJ
        liver_NN from_IN 
        syk_NN -_: deficient_NN mice_NNS has_VBZ demonstrated_VBN
        a_DT block_NN in_IN the_DT transition_NN from_IN proB_NN cells_NNS to_TO preB_NN cells_NNS ,_,
        indicating_VBG that_DT signal_NN transduction_NN through_IN Syk_NNP is_VBZ required_VBN
        for_IN early_JJ B_NNP cell_NN development_NN [_NN 35_CD 36_CD ]_NN ._. Inactivation_NNP of_IN
        the_DT 
        syk_NN gene_NN in_IN the_DT chicken_NN DT_NNP 40_CD B_NNP cell_NN
        lymphoma_NN leads_VBZ to_TO a_DT loss_NN in_IN the_DT activation_NN of_IN PLCγ_NNP 2_CD ,_, the_DT
        increase_NN in_IN intracellular_NN free_JJ Ca_MD 2_CD +_NN and_CC the_DT apoptotic_JJ
        response_NN following_VBG engagement_NN of_IN the_DT BCR_NNP ._. In_IN contrast_NN ,_,
        BCR-mediated_NNP activation_NN of_IN Lyn_NNP kinase_NN was_VBD largely_RB
        maintained_VBN [_NN 37_CD 38_CD ]_NN ._. The_DT Syk-dependent_NNP signaling_VBG pathway_NN
        appears_VBZ to_TO be_VB facilitated_JJ by_IN the_DT adaptor_NN molecule_NN BLNK_NNP
        (_( also_RB known_VBN as_IN SLP-_NNP 65_CD and_CC BASH_NNP )_) [_NN 39_CD 40_CD 41_CD ]_NN ._. Syk_NNP can_MD
        induce_VB the_DT phosphorylation_NN of_IN BLNK_NNP in_IN co-transfection_JJ
        experiments_NNS [_NN 42_CD ]_NN ,_, which_WDT may_MD be_VB important_JJ for_IN the_DT
        recruitment_NN of_IN other_JJ Syk_NNP substrates_NNS like_IN PLCγ_NNP 2_CD through_IN a_DT
        scaffolding_VBG function_NN [_NN 42_CD ]_NN ._. BLNK_NNP function_NN is_VBZ necessary_JJ
        for_IN signal_NN transduction_NN since_IN no_DT Ca_MD 2_CD +_NN flux_NN or_CC PLCγ_NNP 2_CD
        phosphorylation_NN is_VBZ observed_VBN in_IN response_NN to_TO BCR_NNP engagement_NN
        in_IN BLNK-deficient_NNP DT_NNP 40_CD cells_NNS [_NN 43_CD ]_NN ._.
        The_DT formation_NN of_IN large_JJ protein_NN complexes_NNS associated_VBN with_IN
        the_DT membrane_NN receptor_NN through_IN specific_JJ protein-protein_JJ
        interactions_NNS appears_VBZ to_TO be_VB an_DT early_JJ step_NN in_IN BCR-mediated_NNP
        signal_NN transduction_NN ._. In_IN response_NN to_TO receptor_NN activation_NN ,_,
        Syk_NNP becomes_VBZ non-covalently_JJ associated_VBN with_IN the_DT BCR_NNP through_IN
        tandem_JJ SH_NNP 2_CD domains_NNS located_VBN in_IN the_DT amino_JJ terminal_NN half_NN of_IN
        the_DT protein_NN [_NN 44_CD ]_NN ._. Following_VBG engagement_NN of_IN the_DT BCR_NNP ,_,
        phosphorylation_NN of_IN specific_JJ tyrosine_NN residues_NNS in_IN
        immunoreceptor_NN tyrosine-based_JJ activation_NN motifs_NNS (_( ITAMs_NNP )_)
        found_VBD within_IN the_DT cytoplasmic_JJ tails_NNS of_IN CD_NNP 79_CD a_DT and_NN CD_NNP 79_CD b_SYM
        provides_VBZ docking_VBG sites_NNS for_IN Syk_NNP localization_NN [_NN 45_CD 46_CD 47_CD ]_NN ._.
        The_DT ability_NN of_IN phosphorylated_JJ ITAM_NNP peptides_NNS to_TO selectively_RB
        enhance_VB Syk_NNP kinase_NN activity_NN 
        in_IN vitro_NN suggests_VBZ that_DT recruitment_NN of_IN
        Syk_NNP to_TO the_DT receptor_NN complex_NN may_MD serve_VB to_TO activate_VBP the_DT
        kinase_NN ,_, in_IN part_NN ,_, through_IN allosteric_JJ changes_NNS in_IN the_DT
        structure_NN of_IN the_DT Syk_NNP protein_NN [_NN 44_CD 48_CD 49_CD ]_NN ._. Upon_IN
        activation_NN ,_, Syk_NNP and_CC the_DT receptor_NN complex_JJ become_VB localized_JJ
        in_IN detergent-resistant_JJ cholesterol-rich_JJ membrane_NN
        microdomains_NNS (_( lipid_NN rafts_NNS )_) ,_, resulting_VBG in_IN the_DT segregation_NN of_IN
        the_DT BCR_NNP complex_JJ from_IN other_JJ membrane_NN components_NNS [_NN 50_CD ]_NN ._.
        In_IN this_DT report_NN ,_, we_PRP describe_VBP the_DT use_NN of_IN a_DT mutant_JJ form_NN of_IN
        Syk_NNP that_WDT leads_VBZ to_TO the_DT constitutive_JJ activation_NN of_IN the_DT
        endogenous_JJ wildtype_NN Syk_NNP kinase_NN when_WRB introduced_VBN into_IN B_NNP cells_NNS
        -_: a_DT dominant_JJ positive_JJ effect_NN -_: in_IN the_DT absence_NN of_IN detectable_JJ
        tyrosine_NN phosphorylation_NN ._. It_PRP was_VBD anticipated_VBN that_IN the_DT
        presence_NN of_IN a_DT constitutively_RB active_JJ Syk_NNP enzyme_NN could_MD help_VB
        in_IN delineating_VBG the_DT signaling_VBG events_NNS that_WDT occur_VBP upstream_RB and_CC
        downstream_JJ of_IN Syk_NNP activation_NN in_IN the_DT BCR_NNP signal_NN transduction_NN
        pathway_NN ._. However_RB ,_, although_IN these_DT cells_NNS carry_VBP a_DT highly_RB
        active_JJ Syk_NNP kinase_NN ,_, no_DT evidence_NN for_IN downstream_JJ signaling_VBG was_VBD
        found_VBN ._. These_DT data_NNS indicate_VBP that_DT activation_NN of_IN Syk_NNP kinase_NN
        enzymatic_JJ activity_NN in_IN cells_NNS is_VBZ insufficient_JJ for_IN signal_NN
        transduction_NN ._.
      
      
        Results_NNS
        
          BCR_NNP engagement_NN induces_VBZ apoptosis_NNS and_CC Syk_NNP
          activation_NN
          Stimulation_NNP through_IN the_DT BCR_NNP has_VBZ been_VBN shown_VBN to_TO induce_VB
          changes_NNS in_IN cell_NN growth_NN and_CC viability_NN in_IN several_JJ B_NNP cell_NN
          systems_NNS ,_, including_VBG the_DT human_JJ Daudi_NNP ,_, chicken_NN DT_NNP 40_CD and_CC
          mouse_NN WEHI-_NNP 231_CD and_CC BCL_NNP 
          1_CD ._. 3_CD B_NN 3_CD B_NNP cell_NN lymphomas_NNS [_NN 12_CD 19_CD 27_CD 38_CD
          51_CD 52_CD 53_CD ]_NN ._. For_IN example_NN ,_, stimulation_NN of_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD through_IN the_DT BCR_NNP suppressed_VBD
          exponential_NN population_NN growth_NN in_IN cell_NN culture_NN (_( Figure_NN
          1_CD A_DT )_) ._. Using_VBG flow_NN cytometry_NN to_TO measure_VB membrane_NN
          permeability_NN and_CC DNA_NNP content_NN of_IN cells_NNS ,_, BCR_NNP stimulation_NN
          resulted_VBD in_IN a_DT 5_CD -_: fold_VB increase_NN (_( 6_CD ._. 5_LS to_TO 32_CD ._. 6_CD %_NN )_) in_IN the_DT
          proportion_NN of_IN apoptotic_JJ cells_NNS after_IN 24_CD hrs_NNS (_( Figure_NN
          1_CD B_NNP )_) ._.
          BCR-mediated_NNP tyrosine_NN kinase_NN activation_NN is_VBZ thought_VBN to_TO
          be_VB involved_VBN in_IN the_DT signal_NN transduction_NN cascades_NNS that_WDT give_VBP
          rise_NN to_TO these_DT changes_NNS in_IN cell_NN growth_NN and_CC viability_NN [_NN 19_CD ]_NN
          ._. To_TO determine_VB if_IN BCR_NNP engagement_NN under_IN these_DT conditions_NNS
          leads_VBZ to_TO Syk_NNP kinase_NN activation_NN ,_, increasing_VBG amounts_NNS of_IN
          anti-_NN IgM_NNP were_VBD added_VBN to_TO cultured_JJ BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS ._. An_DT 
          in_IN vitro_NN Syk_NNP specific_JJ
          immune-complex_JJ kinase_NN assay_NN was_VBD used_VBN to_TO measure_VB changes_NNS
          in_IN Syk_NNP activity_NN in_IN response_NN to_TO BCR_NNP stimulation_NN (_( Figure_NN
          2_CD A_DT )_) ._. In_IN unstimulated_JJ and_CC control_NN treated_VBD BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS (_( lanes_NNS 1_CD and_CC 6_CD )_) ,_, low_JJ ,_,
          basal_NN levels_NNS of_IN Syk_NNP activity_NN were_VBD detected_VBN ._. The_DT
          autophosphorylation_NN activity_NN of_IN Syk_NNP increased_VBN
          dramatically_RB with_IN the_DT addition_NN of_IN anti-_NN IgM_NNP ;_: Syk_NNP activity_NN
          responded_VBD in_IN a_DT dose_NN dependent_JJ manner_NN and_CC reached_VBD a_DT
          plateau_NN at_IN 10_CD μg_NN (_( lane_NN 4_LS )_) in_IN which_WDT activity_NN was_VBD ~_NN 15_CD fold_VB
          higher_JJR than_IN in_IN unstimulated_JJ cells_NNS ._.
          The_DT kinetics_NNS of_IN BCR-induced_NNP Syk_NNP activation_NN was_VBD
          analyzed_VBN to_TO determine_VB the_DT rates_NNS of_IN Syk_NNP kinase_NN activation_NN
          and_CC inactivation_NN following_VBG initial_JJ engagement_NN of_IN the_DT BCR_NNP
          (_( Figure_NN 2_CD B_NNP )_) ._. Maximal_NNP Syk_NNP activation_NN occurred_VBD within_IN 1_CD min_NN
          of_IN receptor_NN engagement_NN (_( lane_NN 3_LS )_) and_CC decreased_VBD to_TO
          intermediate_JJ levels_NNS at_IN times_NNS thereafter_RB (_( lanes_NNS 4_CD and_CC 5_LS )_) ._.
          Additional_JJ experiments_NNS revealed_VBD that_IN even_RB 1_CD hour_NN after_IN
          BCR_NNP stimulation_NN ,_, Syk_NNP activity_NN remained_VBD slightly_RB elevated_VBD
          in_IN comparison_NN with_IN unstimulated_JJ cells_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
          The_DT increase_NN in_IN Syk_NNP activity_NN in_IN response_NN to_TO BCR_NNP
          engagement_NN in_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD was_VBD accompanied_VBN by_IN an_DT increase_NN
          in_IN tyrosine_NN phosphorylation_NN of_IN Syk_NNP protein_NN in_IN cells_NNS
          (_( Figure_NN 2_CD C_NNP )_) ._. No_DT phosphorylated_JJ tyrosine_NN residues_NNS were_VBD
          detected_VBN on_IN Syk_NNP in_IN unstimulated_JJ or_CC control_NN treated_VBD cells_NNS
          (_( lanes_NNS 1_CD ,_, 4_CD ,_, and_CC 5_LS )_) ._. Tyrosine_NNP phosphorylation_NN of_IN Syk_NNP
          peaked_VBD after_IN 30_CD seconds_NNS of_IN BCR_NNP stimulation_NN (_( lane_NN 2_LS )_) and_CC
          decreased_VBN by_IN 5_CD minutes_NNS (_( lane_NN 3_LS )_) ._. The_DT rapid_JJ induction_NN of_IN
          tyrosine_NN phosphorylation_NN and_CC its_PRP$ subsequent_JJ reduction_NN
          paralleled_JJ the_DT kinetics_NNS of_IN Syk_NNP kinase_NN activity_NN (_( Figure_NN
          2_CD B_NNP )_) ._.
        
        
          Expression_NNP of_IN a_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) mutant_JJ Syk_NNP results_NNS in_IN a_DT
          dominant_JJ positive_JJ effect_NN
          BCR-mediated_NNP apoptosis_NNS was_VBD preceded_VBN by_IN an_DT increase_NN in_IN
          Syk_NNP kinase_NN activity_NN in_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD ._. Syk_NNP has_VBZ also_RB been_VBN implicated_VBN
          in_IN BCR-induced_NNP apoptosis_NNS found_VBD in_IN the_DT chicken_NN B_NNP lymphoma_NN
          line_NN ,_, DT_NNP 40_CD [_NN 38_CD ]_NN ._. To_TO determine_VB the_DT role_NN of_IN Syk_NNP kinase_NN
          activation_NN in_IN the_DT apoptotic_JJ response_NN in_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD ,_, overexpression_NN of_IN a_DT mutant_JJ
          form_NN of_IN Syk_NNP was_VBD used_VBN in_IN an_DT effort_NN to_TO alter_VB the_DT level_NN of_IN
          Syk_NNP activation_NN following_VBG BCR_NNP engagement_NN ._. Site-specific_NNP
          mutations_NNS were_VBD placed_VBN in_IN two_CD regions_NNS of_IN Syk_NNP ._. A_DT lysine_NN at_IN
          amino_JJ acid_NN position_NN 395_CD ,_, predicted_VBD to_TO be_VB critical_JJ for_IN
          kinase_NN activity_NN ,_, was_VBD replaced_VBN by_IN an_DT alanine_NN (_( Figure_NN 3_CD A_DT )_) ._.
          Three_CD carboxy-terminal_JJ tyrosines_NNS (_( positions_NNS 624_CD -_: 6_CD )_) ,_,
          hypothesized_VBN to_TO play_VB regulatory_JJ roles_NNS ,_, were_VBD replaced_VBN by_IN
          phenylalanines_NNS ._. Based_VBN on_IN the_DT effects_NNS of_IN similar_JJ mutations_NNS
          in_IN other_JJ kinases_NNS it_PRP was_VBD expected_VBN that_IN the_DT combination_NN of_IN
          these_DT replacements_NNS in_IN (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP might_MD produce_VB a_DT
          dominant_JJ negative_JJ effect_NN ._.
          BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS were_VBD infected_VBN with_IN
          defective_JJ retroviruses_NNS expressing_VBG wildtype_NN or_CC (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_)
          mutant_JJ Syk_NNP ._. Clones_NNP expressing_VBG varying_VBG levels_NNS of_IN wildtype_NN
          or_CC mutant_JJ Syk_NNP mRNA_NN were_VBD identified_VBN using_VBG a_DT three-primer_JJ
          reverse_NN transcriptase_NN polymerase_NN chain_NN reaction_NN (_( RT-PCR_NNP )_)
          assay_NN (_( Figure_NN 3_CD B_NNP )_) ._. Using_VBG this_DT approach_NN ,_, PCR_NNP products_NNS
          differing_VBG in_IN size_NN were_VBD simultaneously_RB amplified_VBN from_IN the_DT
          transgene_NN and_CC the_DT endogenous_JJ syk_NN cDNAs_NNS in_IN the_DT same_JJ PCR_NNP
          reaction_NN ._. (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP expression_NN varied_VBD relative_JJ to_TO
          endogenous_JJ Syk_NNP and_CC ranged_VBD from_IN undetectable_JJ levels_NNS
          (_( Figure_NN 3_CD C_NNP ;_: lanes_NNS 8_CD -_: 10_CD )_) to_TO equivalent_NN expression_NN levels_NNS
          (_( lane_NN 4_LS )_) ._. The_DT highest_JJS transgene_NN expression_NN was_VBD found_VBN in_IN
          clone_NN 2_CD ._. 1_CD ._. 2_LS ._.
          The_DT ICKA_NNP was_VBD used_VBN to_TO determine_VB the_DT effect_NN of_IN
          (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP expression_NN on_IN endogenous_JJ Syk_NNP ._. Syk_NNP activity_NN
          was_VBD measured_VBN in_IN parental_JJ BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD (_( Figure_NN 3_CD D_NNP ,_, lanes_NNS 1_CD -_: 3_LS )_) and_CC
          cells_NNS that_WDT express_VBP the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN (_( lanes_NNS 4_CD -_:
          15_CD )_) ._. Surprisingly_RB ,_, cells_NNS that_WDT expressed_VBD the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP
          molecule_NN displayed_VBD constitutive_JJ Syk_NNP activity_NN in_IN
          unstimulated_JJ cells_NNS (_( lanes_NNS 4_CD ,_, 7_CD ,_, and_CC 10_CD )_) ._. A_DT correlation_NN
          between_IN constitutive_JJ kinase_NN activity_NN and_CC mRNA_NN expression_NN
          levels_NNS of_IN (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP was_VBD observed_VBN (_( compare_VB Figure_NN
          3_CD Cwith_NNP Figure_NNP 3_CD D_NNP )_) ;_: clones_NNS with_IN higher_JJR levels_NNS of_IN
          (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP mRNA_NN (_( e_SYM ._. g_SYM ._. clone_NN 2_CD ._. 1_CD ._. 2_LS )_) had_VBD higher_JJR levels_NNS
          of_IN constitutive_JJ kinase_NN activity_NN ,_, while_IN clones_NNS with_IN lower_JJR
          levels_NNS of_IN (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP mRNA_NN (_( e_SYM ._. g_SYM ._. clones_NNS 2_CD ._. 1_CD ._. 6_CD ,_, 2_CD ._. 4_CD ._. 2_LS
          and_CC 2_CD ._. 1_CD ._. 7_CD )_) had_VBD lower_JJR levels_NNS of_IN constitutive_JJ kinase_NN
          activity_NN ._. Thus_RB ,_, it_PRP appeared_VBD that_DT introduction_NN of_IN this_DT
          mutant_JJ form_NN of_IN Syk_NNP resulted_VBD in_IN a_DT dominant_JJ positive_JJ effect_NN
          on_IN kinase_NN activity_NN rather_RB than_IN a_DT dominant_JJ negative_JJ
          effect_NN ._.
          To_TO determine_VB if_IN the_DT observed_VBN Syk_NNP activity_NN is_VBZ an_DT
          artefact_NN of_IN the_DT 
          in_IN vitro_NN assay_NN ,_, a_DT series_NN of_IN immune_JJ
          complex_JJ kinase_NN assays_NNS of_IN Syk_NNP precipitated_VBD from_IN mixtures_NNS
          of_IN lysates_NNS was_VBD performed_VBN ._. Most_JJS significantly_RB ,_, a_DT mixture_NN
          of_IN a_DT lysate_NN from_IN unstimulated_JJ BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS harbouring_VBG wildtype_NN Syk_NNP
          with_IN a_DT lysate_NN from_IN unstimulated_JJ DT_NNP 40_CD expressing_VBG the_DT
          K_NNP 395_CD A_DT ,_, 3_CD F_NN mutant_JJ Syk_NNP (_( see_VB below_IN )_) ,_, at_IN 1_CD :_: 5_CD ,_, 1_CD :_: 1_CD and_CC 5_CD :_: 1_CD
          ratios_NNS ,_, showed_VBD no_DT activity_NN in_IN the_DT immune_JJ complex_JJ kinase_NN
          assay_NN (_( data_NNS not_RB shown_VBN )_) ._. These_DT data_NNS indicate_VBP that_IN the_DT
          mutant_JJ Syk_NNP protein_NN must_MD be_VB expressed_VBN together_RB with_IN the_DT
          wildtype_NN enzyme_NN in_IN cells_NNS to_TO generate_VB the_DT dominant_JJ
          positive_JJ phenotype_NN ,_, and_CC suggest_VBP that_IN it_PRP 's_VBZ effect_NN is_VBZ
          indirect_JJ ._. Although_IN we_PRP cannot_NN rule_NN out_RP the_DT possibility_NN
          that_IN the_DT kinase_NN activation_NN is_VBZ occurring_VBG during_IN the_DT
          isolation_NN procedure_NN ,_, the_DT results_NNS of_IN the_DT mixing_VBG experiment_NN
          suggest_VBP that_IN the_DT wildtype_NN Syk_NNP enzyme_NN is_VBZ active_JJ 
          in_IN vivo_NN under_IN these_DT conditions_NNS ._.
          To_TO determine_VB if_IN expression_NN of_IN the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP mutant_JJ
          resulted_VBD in_IN a_DT change_NN in_IN BCR_NNP responsiveness_NNS ,_, the_DT kinetics_NNS
          of_IN Syk_NNP activation_NN were_VBD measured_VBN in_IN clones_NNS 2_CD ._. 1_CD ._. 2_LS and_CC 2_CD ._. 1_CD ._. 6_CD
          following_VBG BCR_NNP stimulation_NN (_( Figure_NN 3_CD E_NNP )_) ._. Incubation_NNP with_IN
          anti-_NN IgM_NNP induced_VBD a_DT rapid_JJ increase_NN and_CC delayed_VBN reduction_NN
          in_IN Syk_NNP activity_NN with_IN kinetics_NNS similar_JJ to_TO that_DT of_IN control_NN
          clones_NNS ._. Although_IN the_DT basal_NN levels_NNS of_IN Syk_NNP activity_NN were_VBD
          elevated_VBD in_IN clones_NNS that_WDT expressed_VBD the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP
          molecule_NN ,_, the_DT cells_NNS were_VBD still_RB responsive_JJ to_TO BCR_NNP
          signaling_VBG ._.
          To_TO determine_VB if_IN the_DT constitutive_JJ Syk_NNP activity_NN observed_VBD
          in_IN unstimulated_JJ cells_NNS carrying_VBG the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) transgene_NN
          was_VBD accompanied_VBN by_IN constitutive_JJ Syk_NNP tyrosine_NN
          phosphorylation_NN ,_, the_DT levels_NNS of_IN phosphotyrosine_NN on_IN Syk_NNP
          were_VBD determined_VBN by_IN immunoblotting_VBG after_IN
          immunoprecipitation_NN (_( Figure_NN 3_CD F_NN )_) ._. Syk_NNP from_IN unstimulated_JJ
          BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD and_CC vector_NN control_NN clones_NNS had_VBD
          undetectable_JJ levels_NNS of_IN phospho-tyrosine_JJ (_( lanes_NNS 1_CD ,_, 3_CD ,_, 4_CD ,_, and_CC
          6_CD ,_, upper_JJ panel_NN )_) ._. Syk_NNP from_IN unstimulated_JJ clones_NNS carrying_VBG
          the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) transgene_NN ,_, which_WDT had_VBD constitutive_JJ Syk_NNP
          activity_NN ,_, also_RB had_VBD undetectable_JJ levels_NNS of_IN tyrosine_NN
          phosphorylation_NN (_( lane_NN 7_CD ,_, 9_CD ,_, 10_CD and_CC 12_CD ,_, upper_JJ panel_NN )_) ._.
          Thus_RB ,_, despite_IN constitutive_JJ Syk_NNP activity_NN observed_VBD in_IN these_DT
          infectants_NNS ,_, tyrosine_NN phosphorylation_NN did_VBD not_RB correlate_VBP
          with_IN activity_NN (_( compare_VB lanes_NNS 7_CD and_CC 10_CD of_IN Figure_NN 3_CD Dwith_NNP
          lanes_NNS 10_CD and_CC 7_CD of_IN Figure_NN 3_CD F_NN )_) ._. Syk_NNP from_IN all_DT clones_NNS
          analyzed_VBD became_VBD tyrosine_NN phosphorylated_JJ after_IN BCR_NNP
          stimulation_NN (_( lanes_NNS 2_CD ,_, 5_CD ,_, 8_CD and_CC 11_CD )_) ._. It_PRP was_VBD possible_JJ that_IN
          more_JJR Syk_NNP in_IN the_DT immunoprecipitate_NN was_VBD required_VBN for_IN
          detection_NN by_IN the_DT anti-phosphotyrosine_JJ antibody_NN ._. However_RB ,_,
          even_RB when_WRB more_JJR protein_NN was_VBD present_JJ in_IN the_DT
          immunoprecipitate_NN ,_, little_JJ if_IN any_DT phosphotyrosine_NN was_VBD
          detected_VBN in_IN unstimulated_JJ cells_NNS (_( lanes_NNS 13_CD and_CC 15_CD )_) ._. These_DT

          results_NNS indicate_VBP that_IN Syk_NNP activation_NN does_VBZ not_RB require_VB
          tyrosine_NN phosphorylation_NN ._.
          Two_CD hypotheses_NNS were_VBD considered_VBN to_TO explain_VB the_DT high_JJ
          level_NN of_IN Syk_NNP autophosphorylation_NN in_IN the_DT ICKA_NNP ._. In_IN
          unstimulated_JJ clones_NNS expressing_VBG the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP
          molecule_NN ,_, the_DT possibility_NN existed_VBD that_IN the_DT intense_JJ band_NN
          observed_VBD in_IN the_DT ICKA_NNP (_( Figure_NN 3_CD Dlanes_NNP 4_CD ,_, 7_CD ,_, and_CC 10_CD )_) was_VBD
          not_RB due_JJ to_TO increased_VB Syk_NNP activity_NN ,_, but_CC rather_RB to_TO the_DT
          ability_NN of_IN the_DT background_NN levels_NNS of_IN active_JJ endogenous_JJ Syk_NNP
          to_TO preferentially_RB phosphorylate_NN the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP
          molecule_NN due_JJ to_TO possible_JJ changes_NNS in_IN its_PRP$ three-dimensional_JJ
          structure_NN ._. If_IN the_DT kinase_NN activity_NN of_IN Syk_NNP was_VBD truly_RB higher_JJR
          in_IN cells_NNS expressing_VBG (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP ,_, enhanced_JJ
          phosphorylation_NN of_IN an_DT exogenous_JJ substrate_NN would_MD also_RB be_VB
          observed_VBN ._. To_TO examine_VB the_DT ability_NN of_IN Syk_NNP from_IN cells_NNS that_WDT
          expressed_VBD (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP to_TO phosphorylate_NN an_DT exogenous_JJ Syk_NNP
          target_NN ,_, c_SYM 3_CD b-_NN GST_NNP was_VBD added_VBN to_TO the_DT Syk_NNP ICKA_NNP (_( Figure_NN 4_CD ,_,
          lower_JJR panels_NNS )_) ._. The_DT exogenous_JJ substrate_NN was_VBD phosphorylated_JJ
          by_IN Syk_NNP from_IN unstimulated_JJ clones_NNS expressing_VBG the_DT
          (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN (_( lane_NN 7_CD lower_JJR panel_NN )_) ,_,
          demonstrating_VBG that_IN the_DT Syk_NNP enzyme_NN isolated_VBN from_IN these_DT
          cells_NNS was_VBD highly_RB active_JJ ._.
          Although_IN activated_VBN endogenous_JJ Syk_NNP was_VBD the_DT likely_JJ
          source_NN of_IN the_DT constitutive_JJ Syk_NNP activity_NN observed_VBD in_IN
          clones_NNS that_WDT expressed_VBD the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN ,_, the_DT
          possibility_NN remained_VBD that_IN the_DT activity_NN might_MD originate_VB
          from_IN the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN itself_PRP ._. As_IN proof_NN that_IN the_DT
          (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN was_VBD inactive_JJ as_IN predicted_VBN ,_,
          (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP and_CC wildtype_NN Syk_NNP expression_NN constructs_NNS were_VBD
          transfected_JJ into_IN 
          syk_NN -_: negative_JJ DT_NNP 40_CD cells_NNS ,_, and_CC
          activity_NN measured_VBN by_IN the_DT ICKA_NNP (_( Figure_NN 5_LS )_) ._. While_IN wildtype_NN
          human_JJ Syk_NNP was_VBD capable_JJ of_IN autophosphorylation_NN (_( lane_NN 2_CD
          upper_JJ panel_NN )_) ,_, the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP mutant_JJ was_VBD not_RB (_( lanes_NNS 3_CD
          and_CC 4_LS )_) demonstrating_VBG that_IN this_DT molecule_NN was_VBD kinase-dead_JJ ._.
          This_DT result_NN indicates_VBZ that_IN the_DT constitutive_JJ Syk_NNP activity_NN
          identified_VBN in_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD clones_NNS expressing_VBG (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP
          was_VBD likely_JJ due_NN to_TO endogenous_JJ Syk_NNP and_CC not_RB the_DT
          (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP mutant_JJ ._.
          Expression_NNP of_IN the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN resulted_VBD in_IN
          constitutive_JJ activation_NN of_IN Syk_NNP ._. However_RB ,_, overexpression_NN
          of_IN a_DT full-length_JJ unmutated_JJ Syk_NNP might_MD also_RB generate_VB the_DT
          same_JJ phenotype_NN ._. To_TO determine_VB if_IN the_DT constitutive_JJ
          phenotype_NN was_VBD a_DT result_NN of_IN the_DT specific_JJ mutations_NNS
          introduced_VBN or_CC if_IN overexpression_NN of_IN a_DT full-length_JJ Syk_NNP
          molecule_NN was_VBD sufficient_JJ to_TO give_VB high_JJ basal_NN kinase_NN
          activity_NN ,_, Syk_NNP activity_NN was_VBD analyzed_VBN from_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS that_WDT expressed_VBD a_DT wildtype_NN
          human_JJ Syk_NNP transgene_NN (_( Figure_NN 6_CD )_) ._. The_DT levels_NNS of_IN wild-type_JJ
          human_JJ Syk_NNP expression_NN were_VBD determined_VBN using_VBG the_DT
          three-primer_JJ RT-PCR_NNP assay_NN described_VBD earlier_RBR (_( Figure_NN 6_CD A_DT )_) ._.
          Shown_NNP are_VBP representative_NN clones_NNS that_WDT expressed_VBD low_JJ levels_NNS
          or_CC equivalent_NN levels_NNS of_IN human_JJ Syk_NNP mRNA_NN as_IN compared_VBN with_IN
          the_DT levels_NNS of_IN endogenous_JJ Syk_NNP mRNA_NN (_( lanes_NNS 3_CD and_CC 4_CD ,_, upper_JJ
          panel_NN )_) ._. The_DT levels_NNS of_IN Syk_NNP activity_NN in_IN unstimulated_JJ cells_NNS
          expressing_VBG wildtype_NN Syk_NNP were_VBD indistinguishable_JJ from_IN the_DT
          levels_NNS in_IN unstimulated_JJ controls_NNS (_( Figure_NN 6_CD B_NNP ,_, compare_VB lanes_NNS
          1_CD ,_, 4_CD ,_, and_CC 7_CD )_) ._. None_NN of_IN the_DT clones_NNS analyzed_VBD contained_VBN
          elevated_VBD constitutive_JJ Syk_NNP activity_NN in_IN unstimulated_JJ cells_NNS ,_,
          demonstrating_VBG that_IN this_DT phenotype_NN requires_VBZ the_DT presence_NN
          of_IN the_DT unique_JJ mutations_NNS introduced_VBN ._.
        
        
          Constitutive_NNP Syk_NNP activity_NN is_VBZ insufficient_JJ for_IN
          downstream_JJ signaling_VBG
          In_IN 
          syk_NN -_: deficient_NN DT_NNP 40_CD cells_NNS ,_, BCR_NNP
          induced_VBD apoptosis_NNS was_VBD abrogated_JJ indicating_VBG that_IN Syk_NNP was_VBD 
          necessary_JJ for_IN this_DT cellular_JJ
          response_NN [_NN 38_CD ]_NN ._. Having_VBG established_VBN cells_NNS with_IN
          constitutive_JJ Syk_NNP activity_NN ,_, it_PRP was_VBD now_RB possible_JJ to_TO
          establish_VB if_IN Syk_NNP activation_NN is_VBZ 
          sufficient_JJ for_IN any_DT of_IN the_DT signaling_VBG
          responses_NNS ._. However_RB ,_, no_DT impact_NN on_IN cell_NN growth_NN in_IN culture_NN
          was_VBD found_VBN in_IN clones_NNS with_IN high_JJ constitutive_JJ Syk_NNP activity_NN ,_,
          nor_CC was_VBD the_DT growth_NN suppressive_JJ effect_NN of_IN anti-_NN IgM_NNP
          treatment_NN enhanced_VBN (_( Figure_NN 7_CD A_DT )_) ._. Likewise_RB ,_, no_DT significant_JJ
          difference_NN in_IN apoptosis_NNS was_VBD observed_VBN between_IN clones_NNS with_IN
          constitutive_JJ Syk_NNP activity_NN and_CC controls_NNS (_( Figure_NN 7_CD B_NNP )_) ._.
          Thus_RB ,_, Syk_NNP kinase_NN activity_NN alone_RB was_VBD insufficient_JJ to_TO
          signal_VB a_DT cellular_JJ response_NN in_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD ._. However_RB ,_, the_DT presence_NN of_IN Syk_NNP
          kinase_NN activity_NN was_VBD still_RB expected_VBN to_TO lead_VB to_TO increased_VBN
          phosphorylation_NN of_IN protein_NN targets_NNS in_IN the_DT absence_NN of_IN
          stimulation_NN through_IN the_DT BCR_NNP ._. To_TO examine_VB this_DT possibility_NN ,_,
          the_DT levels_NNS of_IN protein_NN phosphotyrosine_NN were_VBD evaluated_VBN by_IN
          immunoblotting_VBG (_( Figure_NN 7_CD C_NNP )_) ._. Basal_NNP levels_NNS of_IN
          phosphotyrosine-containing_JJ protein_NN were_VBD detected_VBN in_IN all_DT
          clones_NNS analyzed_VBD (_( lanes_NNS 1_CD ,_, 4_CD ,_, 7_CD ,_, and_CC 10_CD )_) ._. However_RB ,_, no_DT
          increase_NN was_VBD observed_VBN in_IN cells_NNS with_IN constitutive_JJ Syk_NNP
          activity_NN ._. After_IN stimulation_NN of_IN BCR_NNP ,_, many_JJ intracellular_NN
          proteins_NNS became_VBD highly_RB phosphorylated_JJ on_IN tyrosine_NN to_TO
          equivalent_NN levels_NNS in_IN all_DT clones_NNS ,_, regardless_RB of_IN the_DT level_NN
          of_IN Syk_NNP kinase_NN activity_NN (_( lanes_NNS 2_CD ,_, 5_CD ,_, 8_CD and_CC 11_CD )_) ._. These_DT data_NNS
          indicate_VBP that_IN despite_IN elevated_JJ basal_NN and_CC induced_VBN Syk_NNP
          kinase_NN activity_NN in_IN clones_NNS carrying_VBG the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP
          mutant_JJ ,_, global_JJ phosphorylation_NN of_IN cellular_JJ proteins_NNS was_VBD
          not_RB increased_VBN ._.
          The_DT anti-phosphotyrosine_JJ immunoblot_NN used_VBN is_VBZ a_DT
          relatively_RB crude_NN measure_NN of_IN Syk_NNP kinase_NN activity_NN 
          in_IN vivo_NN ._. The_DT possibility_NN remained_VBD
          that_IN any_DT specific_JJ effects_NNS of_IN constitutive_JJ Syk_NNP on_IN its_PRP$
          downstream_JJ targets_NNS might_MD be_VB masked_VBN by_IN the_DT combined_VBN
          effects_NNS of_IN the_DT other_JJ tyrosine_NN kinases_NNS activated_VBN in_IN
          response_NN to_TO BCR_NNP signaling_VBG ._. To_TO focus_VB the_DT investigation_NN on_IN
          downstream_JJ events_NNS of_IN Syk_NNP activation_NN ,_, the_DT phosphorylation_NN
          state_NN of_IN PLCγ_NNP 2_CD ,_, an_DT authentic_JJ ,_, direct_JJ downstream_JJ target_NN of_IN
          Syk_NNP [_NN 54_CD ]_NN ,_, was_VBD evaluated_VBN ._. No_DT PLCγ_NNP 2_CD phosphorylation_NN was_VBD
          detected_VBN in_IN unstimulated_JJ clones_NNS containing_VBG constitutive_JJ
          Syk_NNP activity_NN (_( Figure_NN 7_CD D_NNP ,_, lanes_NNS 4_CD and_CC 7_CD ,_, upper_JJ panel_NN )_) ._. In_IN
          contrast_NN ,_, PLCγ_NNP 2_CD was_VBD rapidly_RB and_CC highly_RB phosphorylated_JJ
          after_IN stimulation_NN of_IN BCR_NNP (_( lanes_NNS 5_CD and_CC 8_CD )_) ._. As_IN in_IN the_DT total_JJ
          cellular_JJ phosphotyrosine_NN analysis_NN ,_, the_DT levels_NNS of_IN
          phosphotyrosine_NN on_IN PLCγ_NNP 2_CD were_VBD indistinguishable_JJ between_IN
          control_NN and_CC experimental_JJ cell_NN lines_NNS ._.
        
      
      
        Discussion_NNP
        Previous_JJ studies_NNS have_VBP identified_VBN apoptosis_NNS and_CC cell_NN
        cycle_NN arrest_NN as_IN mechanisms_NNS of_IN BCR-induced_NNP growth_NN arrest_NN in_IN
        BCL_NNP 
        1_CD ._. 3_CD B_NNP 3_CD cells_NNS [_NN 19_CD ]_NN ._. The_DT studies_NNS
        presented_VBN here_RB have_VBP demonstrated_VBN that_DT stimulation_NN of_IN the_DT
        BCR_NNP resulted_VBD in_IN the_DT rapid_JJ and_CC transient_JJ activation_NN of_IN the_DT
        non-receptor_JJ tyrosine_NN kinase_NN ,_, Syk_NNP ._. Previous_JJ studies_NNS have_VBP
        implicated_VBN Syk_NNP in_IN BCR-induced_NNP apoptosis_NNS in_IN other_JJ cell_NN lines_NNS
        [_NN 37_CD 38_CD ]_NN ._. To_TO examine_VB the_DT putative_JJ role_NN of_IN Syk_NNP in_IN
        BCR-induced_NNP apoptosis_NNS and_CC cell_NN cycle_NN arrest_NN in_IN BCL_NNP 
        1_CD ._. 3_CD B_NNP 3_CD ,_, we_PRP attempted_VBD to_TO alter_VB Syk_NNP
        activity_NN through_IN the_DT expression_NN of_IN mutant_JJ forms_NNS of_IN Syk_NNP ._.
        When_WRB the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP mutant_JJ was_VBD co-expressed_JJ with_IN
        endogenous_JJ Syk_NNP in_IN BCL_NNP 
        1_CD ._. 3_CD B_NNP 3_CD cells_NNS ,_, a_DT constitutive_JJ Syk_NNP
        activation_NN phenotype_NN was_VBD observed_VBN ._. The_DT presence_NN of_IN elevated_VBD
        Syk_NNP activity_NN allowed_VBD us_PRP to_TO evaluate_VB the_DT role_NN of_IN Syk_NNP
        activation_NN on_IN the_DT growth_NN and_CC viability_NN of_IN BCL_NNP 
        1_CD ._. 3_CD B_NNP 3_CD ,_, and_CC on_IN other_JJ biochemical_JJ changes_NNS
        associated_VBN with_IN BCR_NNP signaling_VBG ._. To_TO our_PRP$ surprise_NN ,_, no_DT evidence_NN
        for_IN downstream_JJ signaling_VBG was_VBD found_VBN in_IN cells_NNS with_IN high_JJ
        levels_NNS of_IN Syk_NNP kinase_NN activity_NN ._.
        Two_CD novel_NN observations_NNS were_VBD obtained_VBN from_IN these_DT studies_NNS ._.
        First_LS ,_, expression_NN of_IN the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN in_IN BCL_NNP 
        1_CD ._. 3_CD B_NNP 3_CD results_NNS in_IN constitutive_JJ
        activation_NN of_IN endogenous_JJ Syk_NNP ._. Since_IN (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP was_VBD
        enzymatically_RB inactive_JJ when_WRB transfected_JJ into_IN Syk-deficient_NNP
        DT_NNP 40_CD cells_NNS ,_, the_DT observed_VBD constitutive_JJ kinase_NN activity_NN must_MD
        be_VB derived_VBN from_IN endogenous_JJ Syk_NNP and_CC not_RB from_IN the_DT
        (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP protein_NN ._. Mutant_NNP molecules_NNS that_WDT inhibit_VBP the_DT
        activation_NN or_CC function_NN of_IN the_DT wildtype_NN counterpart_NN in_IN the_DT
        same_JJ cell_NN have_VBP been_VBN defined_VBN as_IN dominant-negative_JJ molecules_NNS ._.
        Since_IN (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP has_VBZ an_DT activating_VBG effect_NN on_IN endogenous_JJ
        wildtype_NN Syk_NNP ,_, we_PRP propose_VBP that_IN (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP is_VBZ a_DT
        dominant-positive_JJ molecule_NN ._.
        It_PRP is_VBZ likely_JJ that_IN the_DT replacement_NN of_IN the_DT three_CD
        carboxy-terminal_JJ tyrosine_NN residues_NNS with_IN phenylalanine_NN is_VBZ
        necessary_JJ for_IN the_DT dominant-positive_JJ phenotype_NN ._. Zeitlmann_NNP et_CC
        al_NN ._. found_VBD that_DT transfection_NN of_IN a_DT mutant_JJ Syk_NNP expression_NN
        construct_VB carrying_VBG only_RB the_DT 3_CD F_NN alteration_NN into_IN a_DT T_NN cell_NN
        lines_NNS could_MD overcome_VB the_DT need_NN for_IN TCR_NNP occupancy_NN for_IN IL-_NNP 2_CD
        expression_NN in_IN PMA-treated_NNP cells_NNS [_NN 62_CD ]_NN ._. However_RB ,_, since_IN the_DT
        mutant_JJ Syk_NNP used_VBD retained_VBD kinase_NN activity_NN ,_, these_DT studies_NNS
        could_MD not_RB distinguish_VB between_IN a_DT gain-of-function_JJ effect_NN
        versus_CC a_DT dominant-positive_JJ effect_NN as_IN found_VBN here_RB ._.
        The_DT mechanism_NN by_IN which_WDT the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN
        activates_NNS endogenous_JJ Syk_NNP is_VBZ unknown_JJ ._. One_CD hypothesis_NNS is_VBZ that_IN
        a_DT negative_JJ regulator_NN of_IN Syk_NNP is_VBZ bound_VBN and_CC sequestered_VBN by_IN the_DT
        (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP molecule_NN ._. By_IN sequestering_NN this_DT negative_JJ
        regulator_NN ,_, expression_NN of_IN the_DT mutant_JJ Syk_NNP molecules_NNS gives_VBZ
        rise_NN to_TO the_DT activation_NN of_IN the_DT endogenous_JJ wildtype_NN protein_NN
        in_IN the_DT absence_NN of_IN specific_JJ stimulation_NN ,_, leading_VBG to_TO a_DT
        constitutively_RB active_JJ Syk_NNP phenotype_NN ._. Several_JJ negative_JJ
        regulators_NNS of_IN Syk_NNP have_VBP been_VBN reported_VBN ._. BCR-induced_NNP
        interaction_NN between_IN Cbl_NNP and_CC Syk_NNP increases_VBZ the_DT
        susceptibility_NN of_IN Syk_NNP to_TO proteolysis_NNS [_NN 55_CD ]_NN ,_, possibly_RB
        through_IN enhancement_NN of_IN ubiquitination_NN [_NN 56_CD ]_NN ._. Expression_NNP
        of_IN a_DT dominant-negative_JJ SHP-_NNP 1_CD phosphatase_NN in_IN the_DT mature_VBP
        murine_NN B_NNP cell_NN line_NN K_NNP 46_CD resulted_VBD in_IN an_DT increase_NN in_IN
        BCR-induced_NNP Syk_NNP kinase_NN activity_NN as_IN measured_VBN by_IN C_NNP 3_CD b_SYM
        phosphorylation_NN in_IN an_DT ICKA_NNP and_CC enhanced_VBN BCR-induced_NNP Ca_NNP
        2_CD +_NN fluxes_NNS [_NN 57_CD ]_NN ._. It_PRP remains_VBZ to_TO be_VB determined_VBN if_IN
        interference_NN with_IN any_DT of_IN these_DT known_VBN regulatory_JJ proteins_NNS is_VBZ
        responsible_JJ for_IN the_DT dominant-positive_JJ effect_NN ._.
        The_DT second_JJ novel_NN observation_NN ,_, that_IN Syk_NNP kinase_NN enzymatic_JJ
        activity_NN was_VBD insufficient_JJ for_IN signal_NN transduction_NN ,_, suggests_VBZ
        that_IN multiple_JJ biochemical_JJ processes_VBZ may_MD be_VB required_VBN for_IN the_DT
        Syk-dependent_NNP step_NN of_IN signal_NN transduction_NN ._. Presently_NNP ,_, it_PRP is_VBZ
        unclear_JJ what_WP biochemical_JJ changes_NNS ,_, other_JJ than_IN enzymatic_JJ
        activation_NN ,_, are_VBP required_VBN ._. However_RB ,_, in_IN light_NN of_IN the_DT present_JJ
        model_NN of_IN signaling_VBG through_IN the_DT BCR_NNP ,_, perhaps_RB appropriate_JJ
        subcellular_NN localization_NN to_TO the_DT BCR_NNP protein_NN complex_JJ and_CC the_DT
        ITAMs_NNP of_IN CD_NNP 79_CD b_SYM (_( Igβ_NNP )_) is_VBZ also_RB required_VBN ._. In_IN support_NN of_IN this_DT
        hypothesis_NNS ,_, Syk_NNP did_VBD not_RB co-precipitate_JJ with_IN IgM_NNP in_IN
        (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk-containing_NNP cells_NNS ,_, without_IN stimulation_NN (_( data_NNS
        not_RB shown_VBN )_) ._. This_DT is_VBZ not_RB surprising_VBG since_IN the_DT ITAMs_NNP in_IN CD_NNP 79_CD ,_,
        which_WDT are_VBP proposed_VBN to_TO be_VB docking_VBG sites_NNS for_IN Syk_NNP ,_, are_VBP
        unlikely_JJ to_TO be_VB phosphorylated_JJ in_IN the_DT absence_NN of_IN BCR_NNP
        stimulation_NN since_IN phosphorylation_NN of_IN these_DT residues_NNS likely_JJ
        requires_VBZ activation_NN of_IN Src_NNP family_NN tyrosine_NN kinases_NNS
        expressed_VBD in_IN B_NNP cells_NNS ._. Therefore_RB ,_, despite_IN constitutive_JJ Syk_NNP
        kinase_NN activity_NN ,_, the_DT ITAMs_NNP in_IN the_DT
        dominant-positive-expressing_JJ cells_NNS remain_VBP
        hypophosphorylated_JJ because_IN kinases_NNS that_WDT are_VBP upstream_RB of_IN Syk_NNP
        and_CC /_NN or_CC are_VBP Syk_NNP independent_JJ are_VBP not_RB active_JJ in_IN the_DT absence_NN of_IN
        BCR_NNP crosslinking_VBG ._.
        This_DT result_NN implies_VBZ that_IN in_IN addition_NN to_TO enzymatic_JJ
        activation_NN ,_, localization_NN of_IN Syk_NNP to_TO the_DT BCR_NNP might_MD be_VB
        required_VBN for_IN functional_JJ signal_NN transduction_NN ._. There_EX is_VBZ
        precedence_NN for_IN this_DT model_NN ._. Mutation_NNP of_IN tyrosine_NN 130_CD in_IN Syk_NNP
        to_TO glutamic_JJ acid_NN had_VBD two_CD effects_NNS ._. First_LS ,_, the_DT Y_NNP 130_CD E_NNP mutation_NN
        resulted_VBD in_IN constitutive_JJ activity_NN of_IN Syk_NNP ._. Second_JJ ,_, molecules_NNS
        with_IN the_DT Y_NNP 130_CD E_NNP mutations_NNS did_VBD not_RB co-immunoprecipitate_JJ with_IN
        the_DT BCR_NNP [_NN 58_CD ]_NN ._. A_DT second_JJ example_NN involves_VBZ an_DT 
        in_IN vitro_NN model_NN of_IN histamine_NN release_NN
        in_IN the_DT Syk-deficient_NNP RBL-_NNP 2_CD H_NNP 3_CD cell_NN line_NN [_NN 59_CD ]_NN ._. When_WRB
        tyrosines_NNS 519_CD and_CC 520_CD were_VBD mutated_VBN and_CC introduced_VBN into_IN
        Syk-deficient_NNP RBL-_NNP 2_CD H_NNP 3_CD cells_NNS ,_, these_DT Syk_NNP molecules_NNS were_VBD
        capable_JJ of_IN phosphorylation_NN of_IN c_SYM 3_CD b_SYM substrate_NN in_IN an_DT ICKA_NNP ._.
        However_RB ,_, despite_IN this_DT activity_NN ,_, there_EX was_VBD no_DT high_JJ affinity_NN
        IgE_NNP receptor_NN (_( FcεRI_NNP )_) -_: induced_VBN degranulation_NN ._. Further_RB
        analysis_NN demonstrated_VBD neither_DT increases_NNS in_IN phosphotyrosine_NN
        nor_CC phosphorylation_NN of_IN PLCγ_NNP 2_CD ._.
        Alternatively_RB ,_, the_DT absence_NN of_IN signal_NN transduction_NN in_IN the_DT
        presence_NN of_IN Syk_NNP activity_NN may_MD be_VB related_VBN to_TO its_PRP$ ability_NN to_TO
        interact_NN with_IN its_PRP$ downstream_JJ targets_NNS ._. Within_IN Syk_NNP there_EX are_VBP
        two_CD phosphotyrosine-binding_JJ SH_NNP 2_CD domains_NNS ,_, allowing_VBG for_IN
        protein-protein_JJ interactions_NNS ._. In_IN addition_NN ,_, phosphotyrosine_NN
        residues_NNS in_IN Syk_NNP would_MD provide_VB additional_JJ sites_NNS for_IN
        protein-protein_JJ interactions_NNS ._. Perhaps_RB ,_, further_JJ modification_NN
        is_VBZ necessary_JJ to_TO increase_VB its_PRP$ affinity_NN for_IN downstream_JJ
        binding_JJ partners_NNS ,_, e_SYM ._. g_SYM ._. BLNK_NNP or_CC PLCγ_NNP 2_CD ._.
        The_DT absence_NN of_IN signaling_VBG in_IN the_DT presence_NN of_IN constitutive_JJ
        enzymatic_JJ activity_NN described_VBD for_IN Syk_NNP in_IN different_JJ systems_NNS
        implies_VBZ that_DT execution_NN of_IN the_DT Syk-dependent_NNP step_NN in_IN this_DT
        signaling_VBG cascade_NN is_VBZ a_DT multi-step_JJ process_NN ._. Multiple_NNP
        requirements_NNS for_IN progression_NN through_IN this_DT step_NN in_IN the_DT
        signal_NN transduction_NN pathway_NN may_MD serve_VB to_TO integrate_VB the_DT
        cellular_JJ response_NN to_TO multiple_JJ environmental_JJ cues_NNS ._. In_IN this_DT
        case_NN ,_, the_DT ultimate_JJ cellular_JJ response_NN to_TO the_DT activation_NN of_IN
        the_DT BCR_NNP signaling_VBG pathway_NN is_VBZ cell_NN death_NN ._. Each_DT of_IN these_DT
        required_JJ steps_NNS may_MD provide_VB a_DT regulatory_JJ site_NN where_WRB other_JJ
        signal_NN transduction_NN pathways_NNS could_MD intersect_NN the_DT default_NN
        response_NN to_TO antigenic_JJ stimulation_NN giving_VBG rise_NN to_TO an_DT altered_VBN
        cellular_JJ outcome_NN ._.
      
      
        Conclusions_NNP
        In_IN summary_NN ,_, here_RB we_PRP describe_VBP the_DT use_NN of_IN a_DT mutant_JJ Syk_NNP
        construct_VB to_TO produce_VB a_DT dominant-positive_JJ effect_NN on_IN
        endogenous_JJ Syk_NNP activation_NN in_IN the_DT absence_NN of_IN BCR_NNP engagement_NN ._.
        The_DT presence_NN of_IN a_DT dominant-positive_JJ effect_NN under_IN these_DT
        conditions_NNS suggests_VBZ that_IN the_DT Syk_NNP kinase_NN is_VBZ kept_VBN inactive_JJ in_IN
        resting_VBG cells_NNS by_IN an_DT active_JJ suppression_NN mechanisms_NNS ,_, which_WDT is_VBZ
        disrupted_VBN by_IN the_DT presence_NN of_IN the_DT (_( K_NNP 395_CD A_DT /_NN 3_CD F_NN )_) Syk_NNP mutant_JJ ._. The_DT
        specific_JJ target_NN for_IN this_DT dominant-positive_JJ effect_NN remains_VBZ
        to_TO be_VB identified_VBN ._. Although_IN the_DT Syk_NNP enzyme_NN is_VBZ active_JJ under_IN
        these_DT conditions_NNS ,_, it_PRP lacks_VBZ any_DT detectable_JJ phosphorylation_NN
        on_IN tyrosine_NN residues_NNS ._. This_DT observation_NN indicates_VBZ that_IN the_DT
        current_JJ paradigm_NN that_IN Syk_NNP activation_NN results_NNS from_IN tyrosine_NN
        phosphorylation_NN may_MD be_VB incorrect_JJ ._. Finally_RB ,_, the_DT presence_NN of_IN
        a_DT highly_RB active_JJ Syk_NNP enzyme_NN in_IN cells_NNS was_VBD insufficient_JJ for_IN
        downstream_JJ signal_NN transduction_NN as_IN evidenced_VBN by_IN a_DT lack_NN of_IN
        change_NN in_IN global_JJ tyrosine_NN phosphorylation_NN ,_, phosphorylation_NN
        of_IN PLC-γ_NNP 2_CD or_CC enhanced_VBN spontaneous_JJ or_CC induced_VBN apoptosis_NNS ._.
        These_DT data_NNS suggest_VBP that_IN the_DT Syk-dependent_NNP step_NN in_IN signal_NN
        transduction_NN requires_VBZ biochemical_JJ changes_NNS in_IN addition_NN to_TO
        enzymatic_JJ activation_NN ,_, perhaps_RB proper_JJ localization_NN of_IN the_DT
        active_JJ enzyme_NN to_TO a_DT signaling_VBG receptor_NN complex_JJ ._.
      
      
        Methods_NNP
        
          Cell_NNP Culture_NNP
          The_DT 
          in_IN vitro_NN -_: adapted_VBN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cell_NN line_NN was_VBD previously_RB
          selected_VBN from_IN the_DT BCL_NNP 
          1_CD mouse_NN B_NNP cell_NN lymphoma_NN for_IN growth_NN in_IN
          cell_NN culture_NN [_NN 60_CD ]_NN ._. BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS were_VBD grown_VBN in_IN RPMI_NNP
          supplemented_JJ with_IN 25_CD μg_NN /_NN ml_NN gentamycin_NN ,_, 2_CD mM_NN L-_NNP glutamine_NN ,_,
          100_CD U_NNP /_NN ml_NN penicillin_NN ,_, 100_CD U_NNP /_NN ml_NN streptomycin_NN ,_, non-essential_JJ
          amino_JJ acids_NNS (_( 0_CD ._. 1_LS mM_NN each_DT )_) ,_, 1_CD mM_NN sodium_NN pyruvate_NN ,_, 55_CD μM_NN
          β-mercaptoethanol_JJ ,_, and_CC 5_CD %_NN heat-inactivated_JJ fetal_JJ calf_NN
          serum_NN ._. For_IN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD infected_JJ clones_NNS the_DT medium_NN was_VBD
          supplemented_JJ with_IN 1_CD mg_NN /_NN ml_NN G_NNP 418_CD ._. The_DT 
          syk_NN -_: negative_JJ DT_NNP 40_CD chicken_NN B_NNP cell_NN
          line_NN was_VBD obtained_VBN from_IN T_NN ._. Kurosaki_NNP and_CC was_VBD grown_VBN in_IN RPMI_NNP
          supplemented_JJ with_IN 2_CD mM_NN L-_NNP glutamine_NN ,_, 55_CD μM_NN
          β-mercaptoethanol_JJ ,_, 10_CD %_NN heat-inactivated_JJ fetal_JJ calf_NN
          serum_NN ,_, and_CC 2_CD %_NN heat-inactivated_JJ chicken_NN serum_NN ._. For_IN the_DT 
          syk_NN -_: negative_JJ DT_NNP 40_CD transfectants_NNS
          the_DT medium_NN was_VBD supplemented_JJ with_IN 2_CD mg_NN /_NN ml_NN hygromycin_NN B_NNP
          (_( Calbiochem_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ._. All_DT culture_NN medium_NN products_NNS
          were_VBD from_IN Gibco_NNP BRL_NNP (_( Gaithersburg_NNP ,_, MD_NNP )_) ,_, unless_IN otherwise_RB
          specified_VBN ._.
        
        
          Antibodies_NNP
          Polyclonal_NNP rabbit_NN anti-_NN IgM_NNP antibodies_NNS were_VBD used_VBN to_TO
          signal_VB BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD through_IN the_DT BCR_NNP [_NN 27_CD ]_NN ._.
          Polyclonal_NNP rabbit_NN anti-ovalbumin_JJ was_VBD used_VBN as_IN a_DT negative_JJ
          control_NN for_IN activation_NN and_CC immunoprecipitation_NN
          experiments_NNS ._. Both_DT polyclonal_NN antibody_NN preparations_NNS were_VBD
          purified_JJ by_IN affinity_NN chromatography_NN on_IN Sepharose-antigen_NNP
          columns_NNS [_NN 27_CD ]_NN ._. Immunoprecipitation_NNP of_IN Syk_NNP protein_NN
          utilized_JJ an_DT affinity_NN purified_JJ rabbit_NN anti-_NN Syk_NNP antibody_NN
          (_( SC-_NNP 573_CD ,_, Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Santa_NNP Cruz_NNP ,_, CA_NNP ,_, unless_IN
          otherwise_RB specified_VBN )_) ._. Immunoblotting_NNP for_IN the_DT detection_NN of_IN
          Syk_NNP protein_NN utilized_JJ a_DT rabbit_NN anti-_NN Syk_NNP antibody_NN generated_VBN
          against_IN a_DT different_JJ epitope_NN (_( SC-_NNP 1077_CD ,_, Santa_NNP Cruz_NNP
          Biotechnology_NNP )_) ._. An_DT affinity_NN purified_JJ anti-_NN PLCγ_NNP 2_CD antibody_NN
          (_( SC_NNP 406_CD ,_, Santa_NNP Cruz_NNP Biotechnology_NNP )_) ,_, was_VBD used_VBN for_IN both_DT
          immunoprecipitation_NN and_CC immunoblotting_VBG ._. An_DT
          anti-phosphotyrosine_JJ antibody_NN conjugated_JJ to_TO horseradish_NN
          peroxidase_NN (_( SC_NNP 7020_CD ,_, Santa_NNP Cruz_NNP Biotechnology_NNP )_) was_VBD used_VBN
          for_IN the_DT detection_NN of_IN phosphotyrosine-containing_JJ proteins_NNS
          by_IN immunoblotting_VBG ._.
        
        
          Viable_NNP Cell_NNP Counts_NNP and_CC Apoptosis_NNP Determination_NNP by_IN
          Flow_NNP Cytometry_NNP
          Cells_NNP were_VBD plated_JJ in_IN 1_CD ml_NN of_IN growth_NN medium_NN in_IN
          flat-bottom_JJ 24_CD -_: well_RB plates_NNS at_IN a_DT concentration_NN of_IN 2_CD -_: 3_CD ×_NN
          10_CD 5_CD cells_NNS /_NN ml_NN for_IN 24_CD hr_NN before_IN stimulation_NN with_IN
          antibodies_NNS ._. All_DT samples_NNS were_VBD plated_JJ in_IN duplicate_VB unless_IN
          specified_VBN ._. Cells_NNP were_VBD harvested_VBN and_CC washed_VBN twice_RB with_IN PBS_NNP
          containing_VBG 1_CD %_NN fetal_JJ bovine_JJ serum_NN ._. For_IN cell_NN count_NN
          experiments_NNS ,_, viable_JJ cells_NNS were_VBD enumerated_JJ by_IN Trypan_NNP Blue_NNP
          exclusion_NN using_VBG a_DT hemocytometer_NN (_( Sigma-_NNP Aldrich_NNP Inc_NNP ,_, St_NNP ._.
          Louis_NNP ,_, MO_NNP )_) ._. For_IN apoptosis_NNS determinations_NNS ,_, cells_NNS were_VBD
          resuspended_JJ in_IN 50_CD μl_NN of_IN 400_CD μM_NN 7_CD -_: amino_JJ actinomycin_NN D_NNP
          (_( 7_CD -_: AAD_NNP )_) (_( Molecular_NNP Probes_NNP ,_, Inc_NNP ._. ,_, Eugene_NNP ,_, OR_NNP )_) and_CC
          incubated_JJ for_IN 30_CD minutes_NNS in_IN the_DT dark_NN on_IN ice_NN ._. Cells_NNP were_VBD
          then_RB simultaneously_RB fixed_VBN with_IN the_DT addition_NN of_IN 830_CD μl_NN of_IN
          0_CD ._. 5_CD %_NN paraformaldehyde_NN in_IN PBS_NNP and_CC stained_JJ with_IN the_DT
          addition_NN of_IN 220_CD μl_NN of_IN 10_CD μg_NN /_NN ml_NN Hoechst_NNP 33342_CD (_( Molecular_NNP
          Probes_NNP ,_, Inc_NNP ._. )_) containing_VBG 5_CD %_NN Tween-_NNP 20_CD (_( Sigma-_NNP Aldrich_NNP ,_, Inc_NNP )_)
          for_IN at_IN least_JJS 16_CD hours_NNS at_IN 4_CD °_NN C_NNP in_IN the_DT dark_NN ._. Fluorescence_NNP
          data_NNS from_IN 1_CD ×_NN 10_CD 4_CD cells_NNS was_VBD collected_VBN using_VBG a_DT FACStar_NNP ™_NN
          Plus_NNP (_( Becton_NNP Dickinson_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) and_CC analyzed_VBD with_IN
          CELLQUEST_NNP software_NN (_( Becton_NNP Dickinson_NNP )_) ._.
        
        
          Expression_NNP constructs_NNS
          The_DT retroviral_NN vectors_NNS and_CC ecotropic_JJ packaging_NN cell_NN
          line_NN ,_, BOSC_NNP 23_CD ,_, used_VBN were_VBD obtained_VBN from_IN W_NNP ._. Pear_NNP (_( U_NNP ._. Penn_NNP )_)
          and_CC have_VBP been_VBN described_VBN elsewhere_RB [_NN 61_CD ]_NN ._. MSCV_NNP 2_CD ._. 1_LS and_CC
          MSCVhph_NNP contain_VBP the_DT neomycin_NN and_CC hygromycin_NN resistance_NN
          genes_NNS ,_, respectively_RB ._. DNA_NNP carrying_VBG the_DT wildtype_NN 
          syk_NN coding_VBG region_NN was_VBD generated_VBN by_IN
          polymerase_NN chain_NN reaction_NN (_( PCR_NNP )_) using_VBG high_JJ fidelity_NN
          polymerase_NN (_( Perkin_NNP Elmer_NNP ,_, Branchburg_NNP ,_, NJ_NNP )_) forward-_NN
          5_CD '_POS gacacctgccgaggtgtgtg_NN 3_CD '_POS and_CC reverse_NN
          5_CD '_POS gagggaggtggctgacaatc_NN 3_CD '_POS primers_NNS ,_, and_CC random-primed_JJ cDNA_NN
          template_NN derived_VBN from_IN the_DT human_JJ Burkitt_NNP 's_POS lymphoma_NN cell_NN
          line_NN ,_, Daudi_NNP ._. The_DT PCR_NNP product_NN was_VBD cloned_VBN into_IN the_DT TA_NNP
          cloning_VBG vector_NN pCR_NN 3_CD according_VBG to_TO the_DT manufacturer_NN 's_POS
          protocol_NN (_( Invitrogen_NNP ,_, Carlsbad_NNP ,_, CA_NNP )_) ._. pCR_NN 3_CD /_NN syk_NN was_VBD used_VBN as_IN
          a_DT template_NN for_IN introduction_NN of_IN the_DT mutations_NNS described_VBD in_IN
          the_DT text_NN using_VBG the_DT Transformer_NNP Site-_NNP Directed_NNP Mutagenesis_NNP
          Kit_NNP (_( Clontech_NNP ,_, Palo_NNP Alto_NNP ,_, CA_NNP )_) according_VBG to_TO manufacturers_NNS
          instructions_NNS ._. Wildtype_NNP and_CC mutant_JJ syk_NN DNA_NNP fragments_NNS were_VBD
          subcloned_JJ into_IN the_DT EcoRI_NNP site_NN of_IN MSCV_NNP 2_CD ._. 1_LS ._. Wildtype_NNP and_CC
          mutant_JJ syk_NN DNA_NNP fragments_NNS were_VBD further_JJ subcloned_JJ from_IN
          MSCV_NNP 2_CD ._. 1_LS into_IN MSCVhph_NNP following_VBG digestion_NN with_IN BstEII_NNP and_CC
          HpaI_NNP ._.
        
        
          Retroviral_NNP infections_NNS
          MSCV_NNP /_NN syk_NN expression_NN vectors_NNS were_VBD packaged_VBN into_IN viral_JJ
          particles_NNS by_IN transient_JJ transfection_NN of_IN 1_CD ×_NN 10_CD 6_CD BOSC_NNP cells_NNS
          with_IN 15_CD μg_NN of_IN plasmid_NN DNA_NNP /_NN CaPO_NNP 
          4_CD precipitates_NNS [_NN 61_CD ]_NN ._. BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS were_VBD infected_VBN with_IN 500_CD μl_NN
          of_IN a_DT 1_CD :_: 2_CD dilution_NN of_IN viral_JJ supernatant_NN in_IN growth_NN medium_NN
          containing_VBG 4_CD μg_NN /_NN ml_NN polybrene_NN (_( Sigma-_NNP Aldrich_NNP ,_, Inc_NNP ._. )_) ._.
          Stable_NNP infectants_NNS were_VBD selected_VBN in_IN medium_NN supplemented_JJ
          with_IN 1_CD mg_NN /_NN ml_NN G_NNP 418_CD and_CC 15_CD %_NN BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD -_: conditioned_VBN medium_NN ._. Single_NNP cell_NN
          clones_NNS were_VBD generated_VBN by_IN limiting_VBG dilution_NN ._. 
          syk_NN -_: negative_JJ DT_NNP 40_CD cells_NNS were_VBD
          transfected_JJ by_IN electroporation_NN at_IN 950_CD μFarads_NNS ,_, 0_CD ._. 25_CD kV_NN in_IN
          PBS_NNP using_VBG an_DT electroporator_NN (_( BioRad_NNP ,_, Hercules_NNP ,_, CA_NNP ._. )_) ._.
          Expression_NNP vectors_NNS conferring_VBG hygromycin_NN resistance_NN and_CC
          containing_VBG wildtype_NN or_CC mutant_JJ Syk_NNP were_VBD used_VBN ._.
          Transfectants_NNP were_VBD selected_VBN in_IN RPMI_NNP supplemented_JJ with_IN
          L-_NNP glutamine_NN ,_, β-mercaptoethanol_JJ and_CC hygromycin_NN B_NNP ._. Bulk_NNP
          culture_NN 
          syk_NN -_: negative_JJ DT_NNP 40_CD transfectants_NNS
          were_VBD used_VBN in_IN the_DT specified_VBN experiments_NNS ._.
        
        
          Immune_NNP complex_JJ kinase_NN assay_NN (_( ICKA_NNP )_)
          3_LS -_: 5_CD ×_NN 10_CD 6_CD BCL_NNP 
          1_CD ._. 3_CD B_NNP 3_CD cells_NNS and_CC infectants_NNS were_VBD
          stimulated_VBN with_IN 15_CD μg_NN of_IN affinity_NN purified_JJ rabbit_NN
          anti-mouse_JJ IgM_NNP or_CC anti-ovalbumin_JJ antibody_NN at_IN 37_CD °_NN C_NNP for_IN 30_CD
          sec_NN (_( unless_IN otherwise_RB specified_VBN )_) ._. Stimulated_NNP cells_NNS were_VBD
          then_RB resuspended_JJ in_IN Lysis_NNP Buffer_NNP containing_VBG 5_CD %_NN nonidet_NN
          P-_NNP 40_CD (_( NP-_NNP 40_CD ,_, Sigma-_NNP Aldrich_NNP ,_, Inc_NNP ._. )_) ._. After_IN 15_CD min_NN ,_, Lysis_NNP
          Buffer_NNP was_VBD added_VBN so_IN that_IN the_DT final_JJ NP_NNP 40_CD concentration_NN was_VBD
          1_CD %_NN ._. Lysis_NNP Buffer_NNP contained_VBD 25_CD mM_NN Tris-_NNP HCl_NNP pH_NN 7_CD ._. 4_CD ,_, 150_CD mM_NN
          NaCl_NNP ,_, 1_CD μg_NN /_NN ml_NN aprotinin_NN ,_, 10_CD μg_NN /_NN ml_NN leupeptin_NN ,_, 1_CD mM_NN EDTA_NNP ,_,
          50_CD mM_NN NaF_NNP ,_, and_CC 1_CD mM_NN Na_NNP orthovanadate_NN (_( all_DT from_IN
          Sigma-_NNP Aldrich_NNP ,_, Inc_NNP ._. )_) ._. Nuclei_NNP were_VBD removed_VBN by_IN
          centrifugation_NN at_IN 18_CD ,_, 000_CD ×_NN g_SYM at_IN 4_CD °_NN C_NNP ._. Supernatants_NNP were_VBD
          recovered_VBN and_CC incubated_JJ with_IN protein-_NN A_DT agarose_NN beads_NNS
          (_( Gibco_NNP BRL_NNP )_) coated_VBN with_IN a_DT rabbit_NN anti-_NN Syk_NNP antibody_NN
          (_( SC-_NNP 573_CD ,_, Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Inc_NNP ._. )_) for_IN 30_CD min_NN ._. The_DT
          immunoprecipitates_NNS were_VBD pelleted_JJ ,_, washed_VBD three_CD times_NNS with_IN
          wash_NN buffer_NN (_( 1_CD X_NNP TBS_NNP pH_NN 7_CD ._. 5_LS ,_, 0_CD ._. 5_CD %_NN Triton_NNP X_NNP 100_CD )_) and_CC
          resuspended_JJ in_IN Kinase_NNP Buffer_NNP -_: 20_CD mM_NN Tris-_NNP HCl_NNP pH_NN 7_CD ._. 5_CD ,_, 5_CD
          mM_NN MgCl_NNP 
          2_CD and_CC 5_CD mM_NN MnCl_NNP 
          2_CD (_( all_DT from_IN Sigma-_NNP Aldrich_NNP ,_, Inc_NNP ._. )_) ._.
          Samples_NNP were_VBD then_RB incubated_JJ with_IN 10_CD μCi_NN [_NN γ-_NN 32_CD P_NN ]_NN /_NN 1_CD ._. 6_CD pmol_NN
          ATP_NNP (_( Amersham-_NNP Pharmacia_NNP Biotech_NNP ,_, Inc_NNP ._. ,_, Piscataway_NNP ,_, NJ_NNP ._. )_)
          for_IN 20_CD min_NN at_IN room_NN temperature_NN ._. SDS_NNP Sample_NNP Buffer_NNP was_VBD
          added_VBN ,_, and_CC the_DT samples_NNS resolved_VBN by_IN SDS-PAGE_NNP (_( 9_CD %_NN
          polyacrylamide_NN ,_, BioRad_NNP )_) under_IN reducing_VBG conditions_NNS unless_IN
          otherwise_RB specified_VBN ._. The_DT results_NNS were_VBD visualized_JJ and_CC
          analyzed_VBD using_VBG a_DT phosphorimager_NN (_( Molecular_NNP Dynamics_NNP ,_,
          Sunnyvale_NNP ,_, CA_NNP )_) ._. Low_NNP molecular_JJ weight_NN protein_NN markers_NNS
          (_( Boehringer_NNP Mannheim_NNP /_NN Roche_NNP Molecular_NNP Biochemicals_NNP ,_,
          Indianapolis_NNP ,_, IN_IN )_) were_VBD used_VBN as_IN migration_NN standards_NNS ._. In_IN
          some_DT experiments_NNS ,_, rabbit_NN anti-mouse_JJ IgM_NNP was_VBD added_VBN to_TO
          control_VB cells_NNS during_IN the_DT lysis_NNS step_VBP ;_: under_IN these_DT
          conditions_NNS no_DT stimulation_NN of_IN Syk_NNP phosphorylation_NN or_CC
          kinase_NN activity_NN was_VBD observed_VBN ._.
        
        
          Immunoprecipitation_NNP and_CC immunoblotting_VBG
          Immunoprecipitates_NNP were_VBD generated_VBN from_IN 2_CD ×_NN 10_CD 7_CD cells_NNS
          as_IN described_VBN for_IN the_DT ICKA_NNP except_IN that_IN the_DT
          immunoprecipitates_NNS were_VBD washed_VBN once_RB with_IN PBS_NNP and_CC
          resuspended_JJ in_IN SDS_NNP Sample_NNP Buffer_NNP ._. 10_CD μl_NN of_IN
          immunoprecipitated_JJ protein_NN were_VBD loaded_VBN per_IN sample_NN ._.
          Samples_NNP were_VBD resolved_VBN by_IN SDS-PAGE_NNP (_( 9_CD %_NN polyacrylamide_NN )_) and_CC
          electrophoretically_RB transferred_VBN to_TO nitrocellulose_NN filters_NNS
          (_( BioRad_NNP )_) ._. For_IN Syk_NNP and_CC PLCγ_NNP 2_CD detection_NN ,_, filters_NNS were_VBD
          blocked_VBN with_IN 5_CD %_NN non-fat_JJ dry_JJ milk_NN (_( BioRad_NNP )_) ._. For_IN detection_NN
          of_IN phosphotyrosine-containing_JJ proteins_NNS ,_, filters_NNS were_VBD
          blocked_VBN with_IN 1_CD %_NN bovine_JJ serum_NN albumin_NN (_( Sigma-_NNP Aldrich_NNP )_) ._.
        
      
      
        List_NN of_IN abbreviations_NNS
        IgM_NNP -_: immunoglobulin_NN of_IN the_DT M_NNP isotype_NN ;_: ova_NN -_: chicken_NN
        ovalbumin_NN ;_: PY_NNP -_: phosphotyrosine_NN ;_: PLCγ_NNP 2_CD -_: phospholipase_NN C_NNP
        γ_NN 2_CD ;_: anti_NN -_: antibody_NN or_CC antiserum_NN generated_VBN against_IN
        indicated_JJ antigen_NN ;_: RT-PCR_NNP -_: reverse_VB transcriptase_NN
        polymerase_NN chain_NN reaction_NN ;_: ICKA_NNP -_: immune-complex_JJ kinase_NN
        assay_NN ;_: ITAM_NNP -_: immunoreceptor_NN tyrosine-based_JJ activation_NN
        motifs_NNS ;_: SH_NNP 2_CD and_CC SH_NNP 3_CD -_: Src_NNP homology_NN domains_NNS 2_CD and_CC 3_CD ;_: PBS_NNP -_:
        phosphate-buffered_JJ saline_NN ._.
      
      
        Authors_NNP '_'' contributions_NNS
        RCH_NNP carried_VBD out_RP the_DT biochemical_JJ experiments_NNS to_TO
        characterize_VB the_DT dominant-positive_JJ effect_NN and_CC its_PRP$ influence_NN
        on_IN signal_NN transduction_NN ,_, and_CC drafted_VBD the_DT manuscript_NN ._. AMH_NNP and_CC
        JL_NNP helped_VBD to_TO define_VB the_DT effects_NNS of_IN BCR-mediated_NNP signal_NN
        transduction_NN on_IN the_DT growth_NN and_CC apoptosis_NNS of_IN BCL_NNP 
        1_CD ._. 3_CD B_NNP 3_CD ._. JWH_NNP participated_VBD in_IN the_DT design_NN
        of_IN the_DT studies_NNS described_VBD and_CC in_IN the_DT initial_JJ development_NN of_IN
        the_DT BCL_NNP 
        1_CD ._. 3_CD B_NNP 3_CD system_NN ._. RHS_NNP conceived_VBD of_IN the_DT
        study_NN ,_, and_CC participated_VBD in_IN its_PRP$ design_NN and_CC coordination_NN ._.
      
    
  
